306 results on '"McMullen, Julie R."'
Search Results
2. A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology
3. IGF1–PI3K-induced physiological cardiac hypertrophy: Implications for new heart failure therapies, biomarkers, and predicting cardiotoxicity
4. Loss of the long non-coding RNA OIP5-AS1 exacerbates heart failure in a sex-specific manner
5. Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review
6. Deletion of the muscle enriched lncRNA Oip5os1 induces atrial dysfunction in male mice with diabetes
7. A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology
8. Phosphoinositide 3-Kinase(p110α) Plays a Critical Role for the Induction of Physiological, but Not Pathological, Cardiac Hypertrophy
9. PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart
10. In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function
11. Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
12. Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity
13. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function
14. Author Correction: PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart
15. Protective Effects of Exercise and Phosphoinositide 3-Kinase(p110α) Signaling in Dilated and Hypertrophic Cardiomyopathy
16. Gata4 Is Required for Maintenance of Postnatal Cardiac Function and Protection from Pressure Overload-Induced Heart Failure
17. A protocol for rapid and parallel isolation of myocytes and non-myocytes from multiple mouse hearts
18. Tissue-specific expression of Cas9 has no impact on whole-body metabolism in four transgenic mouse lines
19. Overexpression of Heat Shock Protein 70 Improves Cardiac Remodeling and Survival in Protein Phosphatase 2A-Expressing Transgenic Mice with Chronic Heart Failure
20. Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload
21. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K
22. Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart
23. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
24. Enhanced cardiac PI3Kα signalling mitigates arrhythmogenic electrical remodelling in pathological hypertrophy and heart failure
25. Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients With Type 2 Diabetes
26. Andersen–Tawil Syndrome Is Associated With Impaired PIP2 Regulation of the Potassium Channel Kir2.1
27. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes
28. Homeostatic regulation of electrical excitability in physiological cardiac hypertrophy
29. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism
30. Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
31. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism
32. Non-coding RNAs regulating cardiac muscle mass
33. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling
34. CORP: Practical tools for improving experimental design and reporting of laboratory studies of cardiovascular physiology and metabolism
35. Noncoding RNAs regulating cardiac muscle mass
36. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling
37. Inhibition of heat shock protein 70 blocks the development of cardiac hypertrophy by modulating the phosphorylation of histone deacetylase 2
38. Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients With Type 2 Diabetes.
39. βAdrenergic stimulation induces histone deacetylase 5 (HDAC5) nuclear accumulation in cardiomyocytes by B55α-PP2A-mediated dephosphorylation
40. β‐Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5) Nuclear Accumulation in Cardiomyocytes by B55α‐PP2A‐Mediated Dephosphorylation
41. Andersen–Tawil Syndrome Is Associated With Impaired PIP2 Regulation of the Potassium Channel Kir2.1.
42. Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges
43. Lipidomic Profiles of the Heart and Circulation in Response to Exercise versus Cardiac Pathology: A Resource of Potential Biomarkers and Drug Targets
44. Improving the quality of preclinical research echocardiography: observations, training, and guidelines for measurement
45. Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β2-adrenoceptor overexpression
46. Divergent Effects of PKC (Protein Kinase C) α in the Human and Animal Heart?
47. Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts
48. The Interplay of Protein Coding and Non-Coding RNAs (circRNAs, lncRNAs) During Cardiac Differentiation
49. Abstract 394: Medium Chain Acyl-Coenzyme a Dehydrogenase Gene Therapy Induces Physiological Cardiac Hypertrophy and Protects Against Pathological Remodeling
50. HSP70: therapeutic potential in acute and chronic cardiac disease settings
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.